ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JESUS RIVERO MD

CAROLINA SHOPPING COURT SUITE 311 6TH FLOOR

Carolina | Puerto Rico | 00986

(787) 276-8763

Incorrect Info?
Search this name in Dollars for Docs »

At A Glance: This Prescriber in 2012

Geriatric Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,140Medicare Part D Prescriptions Filled, Including Refills
$1.18M Total Retail Price of All Prescriptions
812 Patients Receiving at Least One Drug in Part D
23%Patients 65 Years and Older
2% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
CYMBALTA 1,437 269 10
AMITRIPTYLINE HCL 1,414 267 R 10
TRAZODONE HCL 1,169 205
FLUOXETINE HCL 1,133 257
LAMOTRIGINE 761 84
QUETIAPINE FUMARATE 719 143
BUPROPION XL 685 47 10
SERTRALINE HCL 624 255
ZOLPIDEM TARTRATE 606 49
SEROQUEL XR 604 47
PAROXETINE HCL 593 190
MIRTAZAPINE 553 72
PRISTIQ ER 522 126 10
RISPERIDONE 371 132
VENLAFAXINE HCL ER 352 21
DIPHENHYDRAMINE HCL 323 73 R
LITHIUM CARBONATE 309 22
SEROQUEL 295 56
BENZTROPINE MESYLATE 220 47 R
DIVALPROEX SODIUM 211 45
ABILIFY 187 67
HYDROXYZINE PAMOATE 161 21 R
LYRICA 154 0
CITALOPRAM HBR 153 56
BUDEPRION XL 144 0 10
HALOPERIDOL 133 37
CHLORPROMAZINE HCL 127 18
DIVALPROEX SODIUM ER 123 0
OLANZAPINE 103 45
DONEPEZIL HCL 90 76
NORTRIPTYLINE HCL 77 36
NAMENDA 62 62
GABAPENTIN 57 12
DOXEPIN HCL 53 0
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.